Targeting relative risk heterogeneity with causal forests

Vik Shirvaikar, Andrea Storås, Xi Lin +1

The identification of heterogeneous treatment effects (HTE) across subgroups is of significant interest in clinical trial analysis. Several state-of-the-art HTE estimation methods,…